Homology Medicines, Inc. QTTB 深 沪
已收盘 04-02 16:00:00 美东时间
6.38
+0.270
+4.42%
华盛通- 最 高6.62
- 今 开5.92
- 成交量 16.66万股
- 最 低 5.79
- 昨 收 6.11
- 总市值 9333.60万
- 52周最高 8.045
- 市盈率 静 2.63
- 换手率 1.14%
- 52周最低 1.345
- 委 比 -68.64%
- 总股本 1462.95万
- 历史最高 572.40
- 量 比 0.30
- 振 幅 13.58%
- 历史最低 1.345
- 每 手 1
- 风险率 1.39%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Q32 Bio Files Prospectus To Offer And Sell Common Stock Up To $14.2M Through Cantor
-SEC Filing
03-28 05:25
Q32 Bio shares are trading higher after the company reported better-than-expected Q4 adjusted EPS results.
Q32 Bio shares are trading higher after the company reported better-than-expect...
03-11 01:15
Q32 Bio Q4 Adj. EPS $3.65 Beats $(0.98) Estimate, Sales $53.737M
Q32 Bio (NASDAQ:QTTB) reported quarterly earnings of $3.65 per share which beat the analyst consensus estimate of $(0.98) by 473.98 percent. This is a 414.66 percent increase over losses of $(1.16) per share from the
03-10 19:26
美股大行评级 | 大摩将应用材料目标价升至432美元；潜在涨幅200.0%！维尔生物科技获巴克莱升目标价至30美元，维持"超配"评级
今日重点评级关注：巴克莱：维持Vir Biotechnology"超配"评级，目标价从26美元升至30美元；巴克莱：维持Iovance Biotherapeutics"超配"评级，目标价从10美元升至11美元
02-26 09:30
HC Wainwright & Co. Initiates Coverage On Q32 Bio with Buy Rating, Announces Price Target of $13
HC Wainwright & Co. analyst Joseph Pantginis initiates coverage on Q32 Bio (NASDAQ:QTTB) with a Buy rating and announces Price Target of $13.
02-25 20:04
Market-Moving News for December 1st
QTTB: 97% | Q32 Bio Sells Phase 2 Complement Inhibitor ADX-097 To Akebia Therapeutics For $12M Upfront Payment; Co. Eligible To receive Up To $592M In Milestones As Well As Royalties DYAI: 35% | Dyadic
2025-12-01 20:37
Q32 Bio Q3 EPS $(0.60) Beats $(0.99) Estimate
Q32 Bio (NASDAQ:QTTB) reported quarterly losses of $(0.60) per share which beat the analyst consensus estimate of $(0.99) by 39.39 percent. This is a 58.9 percent increase over losses of $(1.46) per share from the same
2025-11-13 20:01
美联储降息再迎大消息，纳指生科创年内新高，纳指生物科技ETF(513290)强势收涨6.22%，连续16日获资金加仓，“吸金”近7300万元
隔夜（10月8日）美股收盘，美股三大指数涨跌不一，纳指涨1.12%，标普500指数涨0.58%，两者均创收盘新高，道指收平。纳斯达克生物科技指数收涨0.89%...
2025-10-09 17:58
Q32 Bio Q2 EPS $(0.78) Beats $(1.29) Estimate
Q32 Bio (NASDAQ:QTTB) reported quarterly losses of $(0.78) per share which beat the analyst consensus estimate of $(1.29) by 39.53 percent. This is a 45.07 percent increase over losses of $(1.42) per share from the same
2025-08-06 20:37
Q32 Bio GAAP EPS of -$0.78
Q32 Bio press release (NASDAQ:QTTB): Q2 GAAP EPS of -$0.78. Cash and cash equivalents were $54.8 million as of June 30, 2025. Q32 Bio believes its cash and cash equivalents are sufficient to fund oper...
2025-08-06 19:45
